Summary of patient responses
| Patient ID . | Response to T-cell infusions . |
|---|---|
| CLL-1 | No objective response |
| CLL-2 | No objective response |
| CLL-3 | No objective response |
| CLL-4 | Not evaluable |
| CLL-5 | Marked reduction in lymphadenopathy at 3 months, subsequently stable for 6 months |
| CLL-6 | Progressive disease |
| CLL-7 | Stable disease, lasting 4 months |
| CLL-8 | Stable disease, lasting > 8 weeks |
| ALL-1 | Persistent B-cell aplasia in BM and peripheral blood |
| Patient ID . | Response to T-cell infusions . |
|---|---|
| CLL-1 | No objective response |
| CLL-2 | No objective response |
| CLL-3 | No objective response |
| CLL-4 | Not evaluable |
| CLL-5 | Marked reduction in lymphadenopathy at 3 months, subsequently stable for 6 months |
| CLL-6 | Progressive disease |
| CLL-7 | Stable disease, lasting 4 months |
| CLL-8 | Stable disease, lasting > 8 weeks |
| ALL-1 | Persistent B-cell aplasia in BM and peripheral blood |